Footwear brand Dr. Martens has announced the appointment of Robert Hanson and Benoit Vauchy as non-executive directors, effective March 26, 2025. Chairman Paul Mason commented, "We are pleased to announce these appointments today. Robert has significant USA and wholesale experience and is a proven consumer brand CEO. Benoit is an experienced...
12 Feb 2025
Dr. Martens revenue for the third quarter to December 29, 2024, was up 3 percent at constant currency and down 3 percent reported to 267 million pounds. DTC revenue for the quarter increased by 1 percent driven by ecommerce revenue growth of 2 percent and retail revenue decline of 1 percent. “I am excited to be CEO of Dr. Martens. Our Q3 trading...
27 Jan 2025
"A huge thank you to Dr. Martens for an incredible decade," said Darren Leon McKoy upon announcing his departure as global creative director of the British shoe brand on LinkedIn. "Exactly 10 years ago, I joined the brand at a time when it was ready to take bold risks," his statement continued. "With an extraordinary group of passionate people,...
6 Jan 2025
2024 seemed to take shape as a period of transition for many of the industry’s biggest players as they looked to swiftly, yet effectively, turn around lacklustre financials and return to growth, profitability or both. To lead such strategies, many took to overhauling their leadership teams, naming new CEOs in the process who have come in guns...
3 Jan 2025
Footwear specialist Dr Martens has swung into the red as its revenue for the half year plunged deeper. For the 26 weeks ended 29 September 2024, revenue dropped 18 percent on actual exchange rates, amounting to 324.6 million pounds. Adjust EBIT, meanwhile, fell into a loss of 4.3 million pounds compared to a profit of 39.7 million pounds in the...
28 Nov 2024
Footwear specialist Dr Martens is believed to have put around 150 roles at its UK and US head offices at risk of redundancy as part of an ongoing cost-saving plan. It is understood that a consultation phase with the impacted employees is already underway according to Drapers, which initially reported the news. Those affected include employees at...
7 Oct 2024
Footwear specialist Dr. Martens has offered a short update on its current trading performance ahead of its annual general meeting. While shareholders may be waiting for some positive news, however, it appears that such a scenario may not be on the horizon. In a regulatory filing, the company said that since the start of this financial year,...
11 Jul 2024
The majority ownership of footwear specialist Dr. Martens has seen a notable shift following a restructuring of holdings within the company’s top investor. Permira V Fund has implemented a restructuring of its holding share in Dr. Martens, through which the newly incorporated Guernsey-based firm, IngreGrsy Limited, has replaced Luxembourg...
13 Jun 2024
In a preliminary results announcement for the full year, Dr. Martens reported revenue decline of 12 percent or 10 percent in constant currency, with DTC revenue up 2 percent or 5 percent constant currency offset by wholesale revenue down 28 percent or 26 percent constant currency driven by USA wholesale. For the first half, the company expects a...
30 May 2024
Dr. Martens expects its FY24 results to be in line with guidance with direct to consumer (DTC) achieving high single-digit growth in the fourth quarter, compared with a 3 percent decline in the previous quarter as a result of good growth across EMEA, a flat outcome in the USA and a very strong result in APAC, led by Japan. However, for FY25, the...
16 Apr 2024
Footwear specialist Dr. Martens is preparing to take on Temu for alleged trademark infringement, launching a lawsuit in an attempt to halt the Chinese marketplace from using keywords associated with the brand. The legal action was taken to the UK’s High Court, according to a report by the Times, for which a case filing alleged that Temu had been...
15 Apr 2024
A shareholder for Dr. Martens is believed to be urging the boot maker to begin a strategic review that could end with a sale in a bid to secure a stronger share price. According to a letter seen by Reuters, investment firm Marathon Partners Equity Management is calling for such a process due to a stalled earnings growth and sharp share price...
4 Apr 2024